Trademark: 90854710
Word
A
Status Date
Monday, November 13, 2023
Filing Date
Thursday, July 29, 2021
Published for Opposition
Tuesday, June 7, 2022
5 Pharmaceutical and biological drugs for the treatment of a variety of human diseases and disorders, namely, cancer and immunological diseases or disorders; pharmaceuticals and biological drugs for use in modulating the immune system
42 Research and development services in the fields of medicine, pharmaceutical science, biotechnology, and cancer immunotherapy; Research and development services, namely, discovery and clinical development of investigational products in the fields of medicine, science, and cancer immunotherapy
The mark consists of a stylized letter "A".
Nov 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2023
Sou Extension 3 Granted
Nov 13, 2023
Sou Extension 3 Filed
Nov 13, 2023
Sou Teas Extension Received
Aug 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2023
Sou Extension 2 Granted
Jul 31, 2023
Sou Extension 2 Filed
Jul 31, 2023
Sou Teas Extension Received
Nov 12, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 10, 2022
Sou Extension 1 Granted
Nov 10, 2022
Sou Extension 1 Filed
Nov 10, 2022
Sou Teas Extension Received
Aug 2, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
May 4, 2022
Approved For Pub - Principal Register
Apr 26, 2022
Assigned To Examiner
Apr 15, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 15, 2022
Teas Change Of Correspondence Received
Apr 15, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 15, 2022
Teas Change Of Owner Address Received
Sep 27, 2021
New Application Office Supplied Data Entered
Aug 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
